You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Host-Donor Chimerism

Showing 1 - 25 of 5,579
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Graft-versus-host Disease, Poor Graft Function, Low Donor T-cell Chimerism Trial in Belgium, Netherlands (Mesenchymal stem

Recruiting
  • Graft-versus-host Disease
  • +2 more
  • Mesenchymal stem cells
  • Edeghem, Antwerpen, Belgium
  • +11 more
Sep 19, 2022

Predict T Cell Chimerism After MSD SCT for SCD?

Recruiting
  • Sickle Cell Disease
  • Alemtuzumab Injection [Campath]
  • Amsterdam, Netherlands
    Amsterdam Medical Centre
Jun 20, 2023

Myeloid Chimerism Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (CliniMACS CD34 Reagent)

Recruiting
  • Myeloid Chimerism
  • CliniMACS CD34 Reagent
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 7, 2022

GVHD Trial in Nantes (drug, radiation, other)

Terminated
  • Graft Versus Host Disease
  • Nantes, France
    Nantes Uh
Jul 13, 2022

GVHD Trial in Tampa (Cultured Treg cells)

Completed
  • Graft Versus Host Disease
  • Cultured Treg cells
  • Tampa, Florida
    H Lee Moffitt Cancer Center
Nov 2, 2022

Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Duarte (Cholestyramine, Leflunomide, Steroid Therapy)

Recruiting
  • Acute Graft Versus Host Disease
  • Hematopoietic and Lymphoid System Neoplasm
  • Duarte, California
    City of Hope Medical Center
Jan 5, 2023

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • sargramostim
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2022

Cell-Free Nucleic Acids Trial (Cell free DNA analysis)

Not yet recruiting
  • Cell-Free Nucleic Acids
  • Cell free DNA analysis
  • (no location specified)
Jan 27, 2022

Chronic GVHD Trial in Sevilla (Regulatory T-cell enriched infusion)

Recruiting
  • Chronic Graft vs Host Disease
  • Regulatory T-cell enriched infusion
  • Sevilla, Spain
    José Antonio Pérez Simón
May 20, 2022

Response Rate Trial in Shanghai (Decitabine)

Completed
  • Response Rate
  • Shanghai, Shanghai, China
    Blood & Marrow Transplantation Center, RuiJin Hospital
May 19, 2021

Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,

Recruiting
  • Stem Cell Transplant Complications
  • +4 more
  • Radiation
  • +7 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Renal Failure Trial in Chicago, Louisville (Enriched Hematopoietic Stem Cell Infusion)

Active, not recruiting
  • Renal Failure
  • Enriched Hematopoietic Stem Cell Infusion
  • Chicago, Illinois
  • +1 more
Jul 15, 2022

GVHD Trial in Shenzhen, Shanghai (PTCY)

Not yet recruiting
  • GVHD
  • Shenzhen, GaungDong, China
  • +1 more
Aug 17, 2023

Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

Active, not recruiting
  • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

Improved Methods of Cell Selection for Bone Marrow Transplant

Recruiting
  • Graft-Versus-Host Disease
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

Completed
  • Myelodysplastic/Myeloproliferative Neoplasm
  • +2 more
  • Decidual stromal cells (DSC)
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Tumor Trial in United States (drug, other, biological)

Recruiting
  • Hematologic and Lymphocytic Disorder
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Placebo Administration
  • +3 more
  • Duarte, California
  • +3 more
Dec 14, 2022

GVHD, Hematopoietic/Lymphoid Cancer Trial in Winston-Salem (fludarabine phosphate, busulfan, cyclophosphamide)

Active, not recruiting
  • Graft Versus Host Disease
  • Hematopoietic/Lymphoid Cancer
  • fludarabine phosphate
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Aug 5, 2022

Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)

Not yet recruiting
  • Severe Aplastic Anemia
  • (no location specified)
Oct 1, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

GVHD Trial in Stanford (donor regulatory T lymphocytes, laboratory biomarker analysis)

Suspended
  • Graft Versus Host Disease
  • donor regulatory T lymphocytes
  • laboratory biomarker analysis
  • Stanford, California
    Stanford University Hospitals and Clinics
Aug 18, 2021

Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

Active, not recruiting
  • Acute Leukemia
  • +14 more
  • Duarte, California
    City of Hope Medical Center
Nov 18, 2022

Kidney Transplant Rejection Trial (MDR-103)

Not yet recruiting
  • Kidney Transplant Rejection
  • MDR-103
  • (no location specified)
Apr 4, 2022

GVHD, Allogeneic Hematopoietic Cell Transplant Recipient Trial in Palo Alto (Regulatory T Cells)

Completed
  • Graft Versus Host Disease
  • Allogeneic Hematopoietic Cell Transplant Recipient
  • Regulatory T Cells
  • Palo Alto, California
    Stanford University, School of Medicine
Sep 20, 2021

Graft Vs Host Disease, Peripheral Blood Stem Cell Transplantation, AML Trial in Germany (Cyclophosphamide, ATG)

Recruiting
  • Graft Vs Host Disease
  • +5 more
  • Augsburg, Germany
  • +15 more
Aug 2, 2022